|
"hsieh hp"的相關文件
顯示項目 176-200 / 265 (共11頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2009-07-23 |
Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity
|
Chiang, YK;Kuo, CC;Wu, YS;Chen, CT;Coumar, MS;Wu, JS;Hsieh, HP;Chang, CY;Jseng, HY;Wu, MH;Leou, JS;Song, JS;Chang, JY;Lyu, PC;Chao, YS;Wu, SY |
| 國家衛生研究院 |
2009-07-03 |
Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers
|
Cheung, CH;Chen, HH;Kuo, CC;Chang, CY;Coumar, MS;Hsieh, HP;Chang, JY |
| 國家衛生研究院 |
2009-06-09 |
Treatment of coronavirus infection
|
Hsu, TA;Hsieh, HP;Chao, YS;Chen, CM;Jan, JT;Liu, HW |
| 國家衛生研究院 |
2009-05-05 |
Indole compounds
|
Hsieh, HP;Liou, JP;Chang, JY;Chang, CW |
| 國家衛生研究院 |
2009-05 |
Down-regulation of survivin enhances sensitivity to BPROL075 in human cancer cells via caspase-independent mechanisms
|
Cheung, CHA;Chang, CY;Hsieh, HP;Chang, JY |
| 國家衛生研究院 |
2009-04-24 |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL |
| 國家衛生研究院 |
2009-04-23 |
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists
|
Lin, CH;Peng, YH;Coumar, MS;Chittimalla, SK;Liao, CC;Lyn, PC;Huang, CC;Lien, TW;Lin, WH;Hsu, JT;Cheng, JH;Chen, X;Wu, JS;Chao, YS;Lee, HJ;Juo, CG;Wu, SY;Hsieh, HP |
| 國家衛生研究院 |
2009-04-17 |
Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents
|
Lai, MJ;Kuo, CC;Yeh, TK;Hsieh, HP;Chen, LT;Pan, WY;Hsu, KY;Chang, JY;Liou, JP |
| 國家衛生研究院 |
2009-04 |
Aurora kinase inhibitors in preclinical and clinical testing
|
Cheung, CH;Coumar, MS;Hsieh, HP;Chang, JY |
| 國家衛生研究院 |
2009-03 |
Advances in Aurora kinase inhibitor patents
|
Coumar, MS;Cheung, CHA;Chang, JY;Hsieh, HP |
| 國家衛生研究院 |
2009-03 |
Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors
|
Hsieh, HP;Coumar, MS;Lin, CW;Reddy, GR;Tsai, MT;Lin, WH;Hsu, TA;Wu, SY |
| 國家衛生研究院 |
2009-02-26 |
Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity
|
Coumar, MS;Leou, JS;Shukla, P;Wu, JS;Dixit, AK;Lin, WH;Chang, CY;Lien, TW;Tan, UK;Chen, CH;Hsu, JTA;Chao, YS;Wu, SY;Hsieh, HP |
| 國家衛生研究院 |
2009-02 |
Aurintricarboxylic acid inhibits influenza virus neuraminidase
|
Hung, HC;Tseng, CP;Yang, JM;Ju, YW;Tseng, SN;Chen, YF;Chao, YS;Hsieh, HP;Shih, SR;Hsu, JTA |
| 國家衛生研究院 |
2009-01-22 |
Pyrrolidine compounds
|
Chao, YS;Chen, X;Hsieh, HP;Jiaang, WT;Wu, SY |
| 國家衛生研究院 |
2008-12-25 |
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents
|
Reddy, GR;Kuo, CC;Tan, UK;Coumar, MS;Chang, CY;Chiang, YK;Lai, MJ;Yeh, JY;Wu, SY;Chang, JY;Liou, JP;Hsieh, HP |
| 國家衛生研究院 |
2008-12-11 |
吲哚化合物
|
Hsieh, HP;Mahindroo, N;Hsu, TA;Huang, CF;Chen, X;Chao, YS |
| 國家衛生研究院 |
2008-11-25 |
Anti-tumor compounds
|
Hsieh, HP;Chao, YS;Liou, JP;Chang, JY;Tung, YS |
| 國家衛生研究院 |
2008-11-11 |
Indole compounds
|
Hsieh, HP;Mahindroo, NH;Hsu, TA;Huang, CF;Chen, X;Chao, YS |
| 國家衛生研究院 |
2008-09-16 |
Pyrrolidine compounds
|
Jiaang, WT;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2008-07-24 |
Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors
|
Liou, JP; Wu, ZY; Kuo, CC; Chang, CY; Lu, PY; Chen, CM; Hsieh, HP; Chang, JY |
| 國家衛生研究院 |
2008-07-21 |
吡咯啉啶化合物
|
Jiaang, WT;Wu, SY;Chen, X;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2008-07-01 |
Pyrrolidine compounds
|
Jiaang, WT;Chen, X;Wu, SY;Hsieh, HP;Chao, YS |
| 國家衛生研究院 |
2008-07 |
Anti-HSV activity of digitoxin and its possible mechanisms
|
Su, CT; Hsu, JTA; Hsieh, HP; Lin, PH; Chen, TC; Kao, CL; Lee, CN; Chang, SY |
| 國立臺灣大學 |
2008-07 |
Anti-HSV activity of digitoxin and its possible mechanisms
|
Su, CT; Hsu, JT; Hsieh, HP; Lin, PH; Chen, TC; Kao, CL; Lee, CN; Chang, SY |
| 國家衛生研究院 |
2008-06-01 |
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors
|
Lin, WH; Song, JS; Chang, TY; Chang, CY; Fu, YN; Yeh, CL; Wu, SH; Huang, YW; Fang, MY; Lien, TW; Hsieh, HP; Chao, YS; Huang, SF; Tsai, SF; Wang, LM; Hsu, JTA; Chen, YR |
顯示項目 176-200 / 265 (共11頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目
|
